March 17 - March 19
US Market Entry Roadshow
Event Navigation
WHAT YOU’LL LEARN:
The 8 Structural Decisions That Determine Success or Failure
The US market represents extraordinary opportunity, but operational complexity and regulatory fragmentation derail more UK expansions than competitive pressure ever will. Navigating 50 tax regimes, understanding why your UK employment contracts could trigger million-dollar liabilities, and knowing whether your structure will make your UK parent a US taxpayer – these aren’t details to figure out later.
In fact, most companies discover critical gaps 12-18 months post-launch, after capital is deployed, entities are formed, and commitments are made. By then, correction is expensive and highly disruptive.
These clinics bring US-based specialists to the UK so you can validate your strategy, stress-test your assumptions, and identify structural vulnerabilities before you commit resources to plans built on incomplete knowledge or UK approaches that don’t translate.
WHO SHOULD ATTEND:
This clinic is designed for founders, CEOs, finance directors, and senior operational leaders directly responsible for US expansion strategy and delivery – whether you’re validating feasibility, finalising structure, fixing early-stage issues, or scaling operations.
If you’re accountable for any aspect of your US market-entry or growth, this is for you.
SCHEDULE:
London – Tue 17 March
Birmingham – Wed 18 March
Manchester – Thu 19 March
*please note, Complimentary for qualified UK scaleups. Only 15 seats available per city. Central locations.
